Spectrum Pharmaceuticals Stock News

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will particip

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced additional exploratory data f

SPPI earnings call for the period ending March 31, 2022.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI ) Q1 2022 Results Conference Call May 12, 2022 4:30 PM ET Company Participants Michael Grabow - Senior Vice President of Corporate Strategy and Operations T

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology BridgeBio Pharma Inc 

HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ: SPPI), with a price target of $10. The analyst projects revenues of $170 million for Rolontis and $328 million for

HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ: SPPI), with a price target of $10. The analyst projects revenues of $170 million for Rolontis and $328 million for

SPPI earnings call for the period ending December 31, 2021.

Spectrum Pharmaceuticals, Inc. (SPPI) CEO Tom Riga on Q4 2021 Results - Earnings Call Transcript

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus AbbVie's Rinvoq Gets Label Expansion To Treat Ulcerative Colitis AbbVie, Inc. (NYSE: ABBV) announced 

Spectrum Pharmaceuticals (NASDAQ:SPPI) is scheduled to announce Q4 earnings results on Wednesday, March 16th, after market close.The consensus EPS Estimate is -$0.18 (+10.0% Y/Y) and…

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) with the stream of -4.02% also noticed, India Regions Financial Corporation (NYSE:RF) encountered a rapid change of -0.41% in the last hour of Friday’s trading session. … The post Sizzling Stock Alert: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Regions Financial Corporation (NYSE:RF) appeared first on Stocks Equity .

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update

Pacira's (PCRX) flagship product, Exparel, has been performing well since its launch. The company's efforts to expand the drug's label also holds promise.

Spectrum Pharmaceuticals Inc (NASDAQ: SPPI ) announced the presentation of safety and efficacy results from Cohort 4 of the ZENITH20 trial evaluating poziotinib in various non-small cell lung cancer settings. The data comes from 70 first-line patients with non-small lung cancer (NSCLC) with HER2 exon 20 insertion mutations who received 16 … Full story available on Benzinga.com